Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving lenvatinib: a retrospective, multicenter cohort study
接受乐伐替尼治疗的甲胎蛋白和不可切除肝细胞癌患者的预后轨迹：一项回顾性多中心队列研究
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14516-y
Zheng, Yitao; Hu, Jingna; Mei, Yingna; Xiang, Yanjun; Lu, Haofeng; Zhu, Jiuting; Pan, Kaile; Cheng, Shuqun; Liu, Yang
